Andrew Hyland, PhD

Dr. Andrew Hyland has more than 25 years of experience doing tobacco control research. He has conducted numerous funded clinical and population-based studies, published more than 300 papers, and is widely recognized nationally and internationally for his expertise, including advisory roles for the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention, the National Cancer Institute and the International Agency for Research on Cancer. From 2006-2016, he served as the Deputy Editor for the scientific journal Tobacco Control, the leading international journal for tobacco control scientists.

As the Chair of the Department of Health Behavior at Roswell Park Comprehensive Cancer Center, he directs the New York State Smokers Quitline and has contracts with the New York State Department of Health to work with community and clinical stakeholders to advance their tobacco control work plan. He serves as the Scientific Leader of the Population Assessment of Tobacco and Health (PATH) study, which is supported by the National Institute on Drug Abuse (NIDA) and the Food and Drug Administration (FDA) to study more than 46,000 adults and children nationally over a 14-year period to understand changes in tobacco use behaviors and health. Dr. Hyland is a co-investigator for the International Tobacco Control Study, tracking cohorts of tobacco users in 29 countries to evaluate tobacco control policies.

View full profile